Holger Willenbring

8.2k total citations · 1 hit paper
54 papers, 6.0k citations indexed

About

Holger Willenbring is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Holger Willenbring has authored 54 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Holger Willenbring's work include Liver physiology and pathology (21 papers), Pluripotent Stem Cells Research (13 papers) and Pancreatic function and diabetes (13 papers). Holger Willenbring is often cited by papers focused on Liver physiology and pathology (21 papers), Pluripotent Stem Cells Research (13 papers) and Pancreatic function and diabetes (13 papers). Holger Willenbring collaborates with scholars based in United States, Germany and Switzerland. Holger Willenbring's co-authors include Markus Grompe, Claudia Mitchell, Milton J. Finegold, Yassmine Akkari, Susan B. Olson, Mark P. Foster, Yann Malato, Muhsen Al-Dhalimy, Yumi Torimaru and Xin Wang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Holger Willenbring

54 papers receiving 6.0k citations

Hit Papers

Cell fusion is the princi... 2003 2026 2010 2018 2003 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cell fusion is the principal source of bone-marrow-derived hepatocytes
    2003 1.2k citations Xin Wang, Holger Willenbring et al. Nature profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Holger Willenbring 2.9k 2.6k 2.2k 986 944 54 6.0k
Wendy M. Mars 2.4k 0.8× 2.4k 0.9× 2.6k 1.2× 725 0.7× 1.1k 1.2× 83 6.2k
William C. Bowen 2.1k 0.7× 2.5k 1.0× 2.8k 1.3× 287 0.3× 1.0k 1.1× 66 5.2k
Bryon E. Petersen 2.6k 0.9× 3.5k 1.4× 2.4k 1.1× 272 0.3× 1.6k 1.7× 78 6.4k
Andrew W. Duncan 4.3k 1.5× 1.1k 0.4× 838 0.4× 624 0.6× 617 0.7× 73 6.7k
Koji Shido 2.4k 0.8× 979 0.4× 712 0.3× 668 0.7× 810 0.9× 32 5.5k
Frédéric P. Lemaigre 3.9k 1.4× 4.3k 1.7× 2.5k 1.1× 976 1.0× 168 0.2× 127 8.0k
Saul J. Sharkis 4.3k 1.5× 1.5k 0.6× 676 0.3× 620 0.6× 2.1k 2.2× 66 7.5k
Elisa Vigna 2.6k 0.9× 1.1k 0.4× 2.2k 1.0× 627 0.6× 167 0.2× 54 4.6k
K. Michael Weidner 3.5k 1.2× 1.5k 0.6× 3.1k 1.4× 398 0.4× 163 0.2× 44 5.8k
Luke Boulter 1.2k 0.4× 1.5k 0.6× 1.8k 0.8× 371 0.4× 127 0.1× 48 3.7k

Countries citing papers authored by Holger Willenbring

Since Specialization
Citations

This map shows the geographic impact of Holger Willenbring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Willenbring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Willenbring more than expected).

Fields of papers citing papers by Holger Willenbring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Willenbring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Willenbring. The network helps show where Holger Willenbring may publish in the future.

Co-authorship network of co-authors of Holger Willenbring

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Willenbring. A scholar is included among the top collaborators of Holger Willenbring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Willenbring. Holger Willenbring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qi, Lin, Aditi Sharma, Erzhen Chen, et al.. (2024). Adipocyte inflammation is the primary driver of hepatic insulin resistance in a human iPSC-based microphysiological system. Nature Communications. 15(1). 7991–7991. 10 indexed citations
2.
Qi, Lin, Yuchen He, Peter‐James H. Zushin, et al.. (2023). Human iPSC‐Derived Proinflammatory Macrophages cause Insulin Resistance in an Isogenic White Adipose Tissue Microphysiological System. Small. 19(34). e2203725–e2203725. 9 indexed citations
3.
Guillou, Dounia Le, et al.. (2023). Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages. Nature Communications. 14(1). 3902–3902. 24 indexed citations
4.
Lee-Montiel, Felipe T., Alexander Laemmle, Verena Charwat, et al.. (2021). Integrated Isogenic Human Induced Pluripotent Stem Cell–Based Liver and Heart Microphysiological Systems Predict Unsafe Drug–Drug Interaction. Frontiers in Pharmacology. 12. 667010–667010. 45 indexed citations
5.
Huck, Ian, Sumedha Gunewardena, Regina Español‐Suñer, Holger Willenbring, & Udayan Apte. (2018). Hepatocyte Nuclear Factor 4 Alpha Activation Is Essential for Termination of Liver Regeneration in Mice. Hepatology. 70(2). 666–681. 74 indexed citations
6.
Schaub, Johanna, Kari A. Huppert, Ashley Cast, et al.. (2018). De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation. Nature. 557(7704). 247–251. 208 indexed citations
7.
Mitchell, Claudia & Holger Willenbring. (2014). Addendum: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nature Protocols. 9(6). 1532–1532. 19 indexed citations
8.
Hentzschel, Franziska, Kathleen Börner, Kirsten Heiß, et al.. (2014). AAV8-Mediated In Vivo Overexpression of miR-155 Enhances the Protective Capacity of Genetically Attenuated Malarial Parasites. Molecular Therapy. 22(12). 2130–2141. 20 indexed citations
9.
Ng, Raymond, Guisheng Song, Garrett R. Roll, Niels Frandsen, & Holger Willenbring. (2012). A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. Journal of Clinical Investigation. 122(3). 1097–1108. 133 indexed citations
10.
D’Alessio, Joseph A., Raymond Ng, Holger Willenbring, & Robert Tjian. (2011). Core promoter recognition complex changes accompany liver development. Proceedings of the National Academy of Sciences. 108(10). 3906–3911. 28 indexed citations
11.
Rountree, Carl Bart, Lopa Mishra, & Holger Willenbring. (2011). Stem Cells in Liver Diseases and Cancer. Hepatology. 55(1). 298–306. 77 indexed citations
12.
Malato, Yann, Nina Schürmann, Raymond Ng, et al.. (2011). Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. Journal of Clinical Investigation. 121(12). 4850–4860. 323 indexed citations
13.
Roll, Garrett R. & Holger Willenbring. (2010). Transplanted nonviable human hepatocytes produce appreciable serum albumin levels in mice. Stem Cell Research. 5(3). 267–270. 9 indexed citations
14.
Mitchell, Claudia & Holger Willenbring. (2008). A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nature Protocols. 3(7). 1167–1170. 420 indexed citations
15.
Ramalho‐Santos, Miguel & Holger Willenbring. (2007). On the Origin of the Term “Stem Cell”. Cell stem cell. 1(1). 35–38. 158 indexed citations
16.
Bailey, Alexis S., Holger Willenbring, Shuguang Jiang, et al.. (2006). Myeloid lineage progenitors give rise to vascular endothelium. Proceedings of the National Academy of Sciences. 103(35). 13156–13161. 158 indexed citations
17.
Rizvi, Adnan Z., John Swain, Paige S. Davies, et al.. (2006). Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proceedings of the National Academy of Sciences. 103(16). 6321–6325. 203 indexed citations
18.
Willenbring, Holger. (2005). Therapeutic cell fusion. British journal of surgery. 92(8). 923–924. 5 indexed citations
19.
Wang, Xin, Holger Willenbring, Yassmine Akkari, et al.. (2003). Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 422(6934). 897–901. 1202 indexed citations breakdown →
20.
Hiort, Olaf, Holger Willenbring, Norbert Albers, et al.. (1996). Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5α-reductase deficiency. European Journal of Pediatrics. 155(6). 445–451. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy M. Mars Breakdown of academic impact, for papers by William C. Bowen Breakdown of academic impact, for papers by Bryon E. Petersen Breakdown of academic impact, for papers by Andrew W. Duncan Breakdown of academic impact, for papers by Koji Shido Breakdown of academic impact, for papers by Frédéric P. Lemaigre Breakdown of academic impact, for papers by Saul J. Sharkis Breakdown of academic impact, for papers by Elisa Vigna Breakdown of academic impact, for papers by K. Michael Weidner Breakdown of academic impact, for papers by Luke Boulter
Rankless by CCL
2026